ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,677Medicare Part D Prescriptions Filled, Including Refills

Rank: 120 out of 1155

$289K Total Retail Price of All Prescriptions

Rank: 247 out of 1155

339 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 339 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

16% of this provider’s 339 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 7,032 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LISINOPRIL 356 322 1 1
HYDROCHLOROTHIAZIDE 314 307 2 9
ATENOLOL 283 272 3 10
LEVOTHYROXINE SODIUM 253 240 4 2
LOVASTATIN 240 227 5 13
FUROSEMIDE 205 195 6 8
AMLODIPINE BESYLATE 194 191 7 6
HYDROCODONE-ACETAMINOPHEN 193 189 S3 8 4
ATORVASTATIN CALCIUM 188 177 9 12
SIMVASTATIN 172 145 10 3
WARFARIN SODIUM 171 163 11 11
METOPROLOL SUCCINATE 137 137 12 17
OMEPRAZOLE 137 136 12 5
METFORMIN HCL 128 111 14 7
POTASSIUM CHLORIDE 117 109 15 16
PRAVASTATIN SODIUM 112 104 16 20
METOPROLOL TARTRATE 106 101 17 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 105 94 18 26
FINASTERIDE 99 99 19 104
DIGOXIN 99 99 19 54
LOSARTAN POTASSIUM 98 98 21 18
ALENDRONATE SODIUM 95 95 22 25
GABAPENTIN 94 55 23 15
FLUOXETINE HCL 93 79 24 30
ALLOPURINOL 90 87 25 29
TRAZODONE HCL 86 65 26 22
ZOLPIDEM TARTRATE 84 84 27 21
GLIPIZIDE 82 75 28 44
TAMSULOSIN HCL 79 79 29 27
NIFEDIPINE ER 73 70 30 189
PAROXETINE HCL 72 68 31 48
CITALOPRAM HBR 66 58 32 19
TRAMADOL HCL 66 52 32 32
DOXAZOSIN MESYLATE 64 58 34 56
ADVAIR DISKUS 63 62 35 35
LOSARTAN-HYDROCHLOROTHIAZIDE 57 57 36 65
DONEPEZIL HCL 54 54 37 41
PROAIR HFA 50 46 38 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.